Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in Japan.

Key Points

• To investigate levels of interleukin-1β in individuals recovering from COVID-19.
• Conducted a nationwide registry study in Japan
• Analyzed interleukin-1β levels in post-COVID-19 patients
• Compared levels to pre-infection baselines
• Found significantly elevated interleukin-1β levels in post-COVID-19 patients
• Indicated chronic inflammation as a potential issue
• Results suggest ongoing immune response in affected individuals